|1.||Benedetti, Fabrizio: 7 articles (02/2015 - 09/2004)|
|2.||Schwacha, Martin G: 5 articles (08/2014 - 01/2006)|
|3.||Rani, Meenakshi: 4 articles (08/2014 - 01/2010)|
|4.||Zhang, Qiong: 4 articles (08/2014 - 01/2010)|
|5.||Bradford, Aidan: 4 articles (04/2014 - 01/2010)|
|6.||O'Halloran, Ken D: 4 articles (04/2014 - 01/2010)|
|7.||Skelly, J Richard: 4 articles (04/2014 - 01/2010)|
|8.||Hagiwara, Satoshi: 4 articles (04/2012 - 03/2009)|
|9.||Noguchi, Takayuki: 4 articles (04/2012 - 03/2009)|
|10.||Kitakoji, Hiroshi: 4 articles (04/2012 - 03/2006)|
09/01/2009 - "The sham treatment group reported a significant reduction in pain rating (p=0.012). "
09/01/2007 - "Although groups were similar during the treatment period, treated subjects (TEMF of 15 mT) improved significantly over sham treatment during the 2-week follow-up period (20.5% reduction in pain; F(1,34) = 10.62, P = 0.003). "
12/01/2014 - "Whether placebos are appropriate and effective in the management of chronic pain in older people deserves considerable attention. "
07/08/1960 - "Evidence is presented to indicate that placebos are far more effective in producing carefully defined relief of pathological pain than they are in the case of experimental pain. "
07/01/2013 - "In contrast, no changes were seen until 12 months following sham treatment (12 months: strength improved by 13 ± 2%, function improved by 52 ± 3%, pain with resistance to extension of the middle finger reduced by 76 ± 2%). "
|2.||Low Back Pain (Lumbago)
12/01/2001 - "Manipulation and mobilization are more effective for chronic low back pain than placebos or usual care for up to 6 months (level 2). "
09/01/2007 - "Prospective, randomized, single-blind, sham treatment-controlled study of the safety and efficacy of an electromagnetic field device for the treatment of chronic low back pain: a pilot study."
07/01/2008 - "Taken together, these results demonstrate that imperfect placebos are common in low back pain trials; a result suggesting that many trials provide potentially biased estimates of treatment efficacy. "
07/01/2008 - "Imperfect placebos are common in low back pain trials: a systematic review of the literature."
10/01/2009 - "Twenty selected patients with chronic low back pain and a positive one-level pressure-controlled provocation discography were randomized to either intra-annular PIRFT or intra-annular sham treatment. "
09/01/2003 - "The cumulative incidence of bleeding events was significantly greater for those participants, compared with participants receiving placebos [hazard ratio, 1.98; 95% confidence interval (CI), 1.19 to 3.28; P = 0.007]. "
01/01/2015 - "Only reports of conjunctival hemorrhage (18.2 vs. 8.5%) and intraocular pressure elevation (13.2 vs. 4.2%) were significantly different in the DEX versus the sham treatment groups. "
01/01/2008 - "DFO injection resulted in significant increases in HIF-1 protein expression and activity in the brainstems of rats with SAH, compared with the rats with SAH that were given placebos, and the rats without SAH in the double-hemorrhage model. "
08/01/2008 - "In the pivotal study, clinical remission rates (Mayo score 0-2, with scores of 0 on rectal bleeding and 0 or 1 on endoscopic examination) were 17% and 11% for the granulocyte/monocyte apheresis (n = 112)- and sham-treatment groups, respectively (n = 56; P = .361). "
03/01/1995 - "Anesthetized Wistar rats were subjected to hemorrhage (7 ml/kg), blood transfusion (7 ml/kg), or sham treatment. "
01/01/1983 - "At the trial end point (21.5 months) the attack-rate for all HBV infections together was 4.8% among vaccinees and 23.8% among the placebos (p less than 0.0001). "
05/01/2007 - "Placebos did not prevent infection in any of the explants tested. "
06/01/1992 - " There were 28 Plasmodium falciparum infections among children taking placebos, and none in those given prophylaxis. "
12/01/2008 - "They exhibited 100-fold lower viral titers in nasal washes than placebos 1 day after treatment, but virus titers were equivalent on days 2-7. CV-N has the potential for prophylaxis and early initiation of treatment of influenza virus infections."
01/01/2013 - "'Impure' placebos are interventions with clear efficacy for certain conditions but are prescribed for ailments where their efficacy is unknown, such as antibiotics for suspected viral infections. "
10/01/1998 - "Published data on the other indications justify prospective, randomized, double-blind, placebo-controlled (sham treatment) trials to confirm efficacy where again the procedure and dosing of shock wave therapy need data-based, rational standardization."
06/01/2005 - "The protocol consisted of three weekly treatments of either low-dose shock wave therapy without anesthetic or a sham treatment. "
12/01/2004 - "Extracorporeal shock waves with energy flux densities between 0 mJ/mm(2) (sham treatment) and 1.2 mJ/mm(2) were applied in vivo to the distal femoral region of rabbits (1500 pulses at 1 Hz frequency each). "
05/01/2002 - "One distal femur of each animal was focussed for shock wave application with different positive energy flux densities (A 1.2 mJ/mm (2), B 0.9 mJ/mm (2), C sham treatment). "
08/01/1980 - "Group-housed adult male Sprague-Dawley rats were given a series of 4 exposures to electroconvulsive shock therapy or equivalent handling without shock (sham treatment). "
|2.||salicylhydroxamic acid (SHAM)
|10.||Anti-Bacterial Agents (Antibiotics)
|2.||Acupuncture Points (Acupuncture Point)
|3.||Phototherapy (Light Therapy)
|4.||Blood Component Removal (Apheresis)